← Back to Search

Aromatherapy Patches for On-Shift Stress

Phase 3
Recruiting
Led By Cheyenne Ruby, DNP
Research Sponsored by Methodist Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up period of 2 months
Awards & highlights

Study Summary

This trial studies how interventions in acute care settings can improve patient care. 100 healthcare workers survey participants at 4 hospitals.

Who is the study for?
This trial is for full-time, part-time, or PRN employees at Methodist Health System facilities who are nurses, patient care technicians, unit secretaries, or in unit-based leadership roles. They must be able to read English and work where a Crisis Intervention Cart is available.Check my eligibility
What is being tested?
The study tests if aromatherapy patches can reduce stress during shifts for healthcare workers. It involves surveying about 100 participants across four health system facilities after they've used the intervention.See study design
What are the potential side effects?
While not explicitly stated here, potential side effects of aromatherapy may include allergic reactions or skin irritation from the patches.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~period of 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and period of 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Crisis Intervention Cart
Secondary outcome measures
Type of intervention/strategy used

Trial Design

1Treatment groups
Experimental Treatment
Group I: Crisis Intervention CartExperimental Treatment1 Intervention
To determine if a Crisis Intervention Cart filled with evidence-based stress-reducing interventions does reduce stress experienced during a shift.

Find a Location

Who is running the clinical trial?

Methodist Health SystemLead Sponsor
152 Previous Clinical Trials
4,825,533 Total Patients Enrolled
Cheyenne Ruby, DNPPrincipal InvestigatorMethodist Health System

Media Library

Crisis Intervention Cart Clinical Trial Eligibility Overview. Trial Name: NCT05944120 — Phase 3
Crisis Intervention Cart Research Study Groups: Crisis Intervention Cart
Crisis Intervention Cart Clinical Trial 2023: Crisis Intervention Cart Highlights & Side Effects. Trial Name: NCT05944120 — Phase 3
Crisis Intervention Cart 2023 Treatment Timeline for Medical Study. Trial Name: NCT05944120 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial accept elderly individuals as participants?

"Candidates aged 18 and over, but below 75 years old are sought to participate in this medical trial."

Answered by AI

To what extent has enrollment been completed for this investigation?

"Confirmed. According to information posted on clinicaltrials.gov, this research endeavour was initially issued on March 6th 2023 and has since been updated on July 6th of the same year. 100 individuals are needed across a single medical facility in order for the study to be completed."

Answered by AI

Are there any restrictions to participation in this clinical experiment?

"To qualify for this trial, participants must possess a crisis intervention cart and belong to the 18-75 year old demographic. A hundred individuals will be accepted in total."

Answered by AI

Are there vacancies for participants in this experiment?

"As per information on clinicaltrials.gov, recruitment for this study is active; it was initially published on March 6th 2023 and its most recent update was made July 6th of the same year."

Answered by AI

Has the Crisis Intervention Cart attained authorization from the FDA?

"Our team at Power has evaluated the Crisis Intervention Cart to be of utmost safety, granting it a rating of 3. This is an indication that there are multiple rounds and sources of clinical data confirming its efficacy and safety."

Answered by AI
~48 spots leftby Apr 2025